Vitamin D and multiple sclerosis |
| |
Authors: | Sarah Hewer Robyn Lucas Ingrid van der Mei Bruce V. Taylor |
| |
Affiliation: | 1. Royal Hobart Hospital, Department of Neurology, Hobart, Tasmania, Australia;2. National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australian Capital Territory, Australia;3. Menzies Research Institute Tasmania, University of Tasmania, Locked Bag 23, Hobart, Tasmania 7000, Australia |
| |
Abstract: | The role of vitamin D supplementation in preventing multiple sclerosis (MS) and/or treating MS progression is an area of significant research interest. We detail the current status of the ongoing research in this field, and note the lack of class 1 evidence from well-conducted, large, double-blind, placebo-controlled studies of vitamin D supplementation in the prevention and/or treatment of MS. We have been able to provide some guidelines for practitioners based on the substantial burden of supportive evidence for the use of vitamin D in MS as summarised here. These guidelines may provide some support to those clinicians who treat people with MS and their families. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|